Dr. Ala Ahmad Suleiman Alkofahi, MD

Dr. Alkofahi practices at Baptist Memorial Hospital-North Mississippi in Oxford, Mississippi, part of Baptist Memorial Health Care.

Dr. Alkofahi's NPI, 1487148987, was assigned on June 18, 2018. Dr. Alkofahi holds Mississippi license 29236.

Dr. Alkofahi's primary practice is Baptist Memorial Hospital-North Mississippi, at 1100 Belk Blvd, Oxford, MS 38655 in Lafayette County. The practice phone is (662) 232-8100.

Dr. Alkofahi's primary practice is Baptist Memorial Hospital-North Mississippi in Oxford, Mississippi, part of Baptist Memorial Health Care. Dr. Alkofahi is also affiliated with Baptist Memorial Hospital-Union County. The medical group on file is North Mississippi Medical Center. Dmand AI also links Dr. Alkofahi to 4 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Alkofahi practices, 6 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Alkofahi's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dmand AI has Dr. Alkofahi's licenses on file in 2 states: Mississippi and Hawaii.

CMS data shows 2,220 Medicare services from Dr. Alkofahi across 7 procedure codes in 2024, for 698 Medicare patients. Medicare paid $202,644 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 698 Medicare patients who saw Dr. Alkofahi in 2024. The largest group is 75 to 84, with 267 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 27% are also on Medicaid. Their average risk score is 2.49, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Alkofahi's median patient age at 75, with 53% women.

In 2024, Dr. Alkofahi wrote 709 Medicare Part D claims for 268 patients. 88% of them were for generic drugs. CMS names the drug for 438 of them, across 22 drugs with 11 or more claims each, at $9,894 in total drug cost. In 2023, CMS named 637 claims across 27 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Alkofahi for performance year 2024, reported as part of a group. Dr. Alkofahi accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Dr. Alkofahi in 2020. 2020 was the busiest year, with 3. Dr. Alkofahi has published most often in Cureus. Dr. Alkofahi's most frequent co-authors are Samer Alkassis, Layla Shanah and Hammad Ali, MD.

CMS Open Payments shows 37 general payments to Dr. Alkofahi from 13 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 100% of the total. Merck Sharp & Dohme Corporation paid the most, $226.